Research News

Revealing Mitochondrial Secret to Cancer Therapy Resistance

New, collaborative work from researchers’ team led by Dr. Shruti Bhatt at National University of Singapore and Dr. Letai at Dana-Farber Cancer Institute has succeeded in understanding the biology of relapsed cancer cells by using mouse models of acute myeloid leukemia (AML), highly aggressive blood cancer.

Read more here: https://aacrjournals.org/bloodcancerdiscov/article-abstract/doi/10.1158/2643-3230.BCD-24-0001/735047/Acquired-Multidrug-Resistance-in-AML-Is-Caused-by?redirectedFrom=fulltext

 

 

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

ZBTB48: A New On-Switch for the Immune Response

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections and cancer …

Read More →
Research News

Magnetic Field Therapy Improves Breast Cancer Treatment with Fewer Side Effects

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, …

Read More →
Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →